Your browser doesn't support javascript.
loading
High Incidence of Noonan Syndrome Features Including Short Stature and Pulmonic Stenosis in Patients carrying NF1 Missense Mutations Affecting p.Arg1809: Genotype-Phenotype Correlation.
Rojnueangnit, Kitiwan; Xie, Jing; Gomes, Alicia; Sharp, Angela; Callens, Tom; Chen, Yunjia; Liu, Ying; Cochran, Meagan; Abbott, Mary-Alice; Atkin, Joan; Babovic-Vuksanovic, Dusica; Barnett, Christopher P; Crenshaw, Melissa; Bartholomew, Dennis W; Basel, Lina; Bellus, Gary; Ben-Shachar, Shay; Bialer, Martin G; Bick, David; Blumberg, Bruce; Cortes, Fanny; David, Karen L; Destree, Anne; Duat-Rodriguez, Anna; Earl, Dawn; Escobar, Luis; Eswara, Marthanda; Ezquieta, Begona; Frayling, Ian M; Frydman, Moshe; Gardner, Kathy; Gripp, Karen W; Hernández-Chico, Concepcion; Heyrman, Kurt; Ibrahim, Jennifer; Janssens, Sandra; Keena, Beth A; Llano-Rivas, Isabel; Leppig, Kathy; McDonald, Marie; Misra, Vinod K; Mulbury, Jennifer; Narayanan, Vinodh; Orenstein, Naama; Galvin-Parton, Patricia; Pedro, Helio; Pivnick, Eniko K; Powell, Cynthia M; Randolph, Linda; Raskin, Salmo.
Afiliação
  • Rojnueangnit K; Department of Genetics, Medical Genomics Laboratory, University of Alabama at Birmingham, Birmingham, Alabama.
  • Xie J; Department of Pediatrics, Faculty of Medicine, Thammasat University, Bangkok, Thailand.
  • Gomes A; Department of Genetics, Medical Genomics Laboratory, University of Alabama at Birmingham, Birmingham, Alabama.
  • Sharp A; Department of Genetics, Medical Genomics Laboratory, University of Alabama at Birmingham, Birmingham, Alabama.
  • Callens T; Department of Genetics, Medical Genomics Laboratory, University of Alabama at Birmingham, Birmingham, Alabama.
  • Chen Y; Department of Genetics, Medical Genomics Laboratory, University of Alabama at Birmingham, Birmingham, Alabama.
  • Liu Y; Department of Genetics, Medical Genomics Laboratory, University of Alabama at Birmingham, Birmingham, Alabama.
  • Cochran M; Department of Genetics, Medical Genomics Laboratory, University of Alabama at Birmingham, Birmingham, Alabama.
  • Abbott MA; Department of Genetics, Medical Genomics Laboratory, University of Alabama at Birmingham, Birmingham, Alabama.
  • Atkin J; Department of Pediatrics, Tufts University School of Medicine, Springfield, Massachusetts.
  • Babovic-Vuksanovic D; Section of Molecular and Human Genetics, Nationwide Children's Hospital, Columbus, Ohio.
  • Barnett CP; Medical Genetics, Mayo Clinic College of Medicine, Rochester, Minnesota.
  • Crenshaw M; Pediatric and Reproductive Genetics, SA Clinical Genetics Service, Women's and Children's Hospital/SA Pathology, North Adelaide, South Australia and Discipline of Pediatrics, University of Adelaide, Adelaide, Australia.
  • Bartholomew DW; Department of Clinical Genetics, All Children's Hospital, John Hopkins Medicine and Department of Pediatrics, John Hopkins University School of Medicine, Baltimore, Maryland.
  • Basel L; Section of Molecular and Human Genetics, Nationwide Children's Hospital, Columbus, Ohio.
  • Bellus G; Raphael Recanati Genetics Institute, Beilinson Campus and Schneider Children's Medical Center of Israel/Felsenstein Medical Research Center, Rabin Medical Center, Petach Tikva, Israel and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Ben-Shachar S; Department of Clinical Genetics and Metabolism, Children's Hospital, University of Colorado, Denver-Aurora, Colorado.
  • Bialer MG; The Genetic Institute, Tel-Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel-Aviv, Israel.
  • Bick D; Department of Pediatrics, North Shore LIJ Health System, Manhasset, New York.
  • Blumberg B; Section of Genetics, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Cortes F; Kaiser Permanente Oakland, Oakland, California.
  • David KL; Center for Rare Diseases, Clinica Las Condes, Santiago, Chile.
  • Destree A; Department of Medicine, Division of Genetics, New York Methodist Hospital, Brooklyn, New York.
  • Duat-Rodriguez A; Institute of Pathology and Genetics (IPG), Gosselies, Belgium.
  • Earl D; Department of Neuropediatrics, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.
  • Escobar L; Department of Pediatrics, Division of Genetic Medicine, University of Washington, and Seattle Children's Hospital, Seattle, Washington.
  • Eswara M; Medical Genetics and Neurodevelopment Center, St Vincent Children's Hospital, Indianapolis, Indiana.
  • Ezquieta B; Sutter Memorial Hospital, Sacramento, California.
  • Frayling IM; Department of Biochemistry, Hospital Universitario Gregorio Marañón, Institute of Health Research (IiSGM), Madrid, Spain.
  • Frydman M; Institute of Medical Genetics, University Hospital of Wales, Cardiff, UK.
  • Gardner K; Chaim Sheba Medical Center, Tel Hashomer, Israel.
  • Gripp KW; Department of Neurology, Veterans Administration Hospital of Pittsburgh and University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Hernández-Chico C; Division of Medical Genetics, AI duPont Hospital for Children, Wilmington, Delaware.
  • Heyrman K; Department of Genetics, Hospital Universitario Ramón y Cajal, Institute of Health Research (IRYCIS). Center for Biomedical Research-Network of Rare Diseases (CIBERER), Madrid, Spain.
  • Ibrahim J; Children's Health Center-Pediatrics, Appleton, Wisconsin.
  • Janssens S; St. Joseph's Children's Hospital, Paterson, New Jersey.
  • Keena BA; Center for Medical Genetics, Ghent University Hospital, Gent, Belgium.
  • Llano-Rivas I; Division of Human Genetics, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania.
  • Leppig K; Department of Genetics, Hospital Universitario Cruces, BioCruces Health Research Institute, Biscay, Spain.
  • McDonald M; Genetic Services, Group Health Cooperative and Department of Pathology, University of Washington, Seattle, Washington.
  • Misra VK; Department of Pediatrics, Division of Medical Genetics, Duke University Medical Center, Durham, North Carolina.
  • Mulbury J; Department of Pediatrics, Division of Genetics and Metabolic Disorders, The Wayne State University School of Medicine, Detroit, Michigan.
  • Narayanan V; Department of Pediatrics and Neurology, University of Rochester Medical center, Rochester, New York.
  • Orenstein N; Dorrance Center for Rare Childhood Disorders, Translational Genomics Research Institute (TGen), Phoenix, Arizona.
  • Galvin-Parton P; Genetics Unit, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
  • Pedro H; Stony Brook Children's, Stony Brook Medicine, Stony Brook, New York.
  • Pivnick EK; Medical Genetics, Hackensack University Medical Center, Hackensack, New Jersey.
  • Powell CM; Department of Pediatrics, Division of Medical Genetics and Department of Ophthalmology University of Tennessee Health Science Center and Le Bonheur Children's Hospita l, Memphis, Tennessee.
  • Randolph L; Department of Pediatrics, University of North Carolina, Chapel Hill, North Carolina.
  • Raskin S; Division of Medical Genetics, Children's Hospital Los Angeles, Los Angeles, California.
Hum Mutat ; 36(11): 1052-63, 2015 Nov.
Article em En | MEDLINE | ID: mdl-26178382
ABSTRACT
Neurofibromatosis type 1 (NF1) is one of the most frequent genetic disorders, affecting 13,000 worldwide. Identification of genotype-phenotype correlations is challenging because of the wide range clinical variability, the progressive nature of the disorder, and extreme diversity of the mutational spectrum. We report 136 individuals with a distinct phenotype carrying one of five different NF1 missense mutations affecting p.Arg1809. Patients presented with multiple café-au-lait macules (CALM) with or without freckling and Lisch nodules, but no externally visible plexiform neurofibromas or clear cutaneous neurofibromas were found. About 25% of the individuals had Noonan-like features. Pulmonic stenosis and short stature were significantly more prevalent compared with classic cohorts (P < 0.0001). Developmental delays and/or learning disabilities were reported in over 50% of patients. Melanocytes cultured from a CALM in a segmental NF1-patient showed two different somatic NF1 mutations, p.Arg1809Cys and a multi-exon deletion, providing genetic evidence that p.Arg1809Cys is a loss-of-function mutation in the melanocytes and causes a pigmentary phenotype. Constitutional missense mutations at p.Arg1809 affect 1.23% of unrelated NF1 probands in the UAB cohort, therefore this specific NF1 genotype-phenotype correlation will affect counseling and management of a significant number of patients.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Fenótipo / Códon / Substituição de Aminoácidos / Mutação de Sentido Incorreto / Neurofibromina 1 / Síndrome de Noonan Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Idioma: En Revista: Hum Mutat Assunto da revista: GENETICA MEDICA Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Fenótipo / Códon / Substituição de Aminoácidos / Mutação de Sentido Incorreto / Neurofibromina 1 / Síndrome de Noonan Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Idioma: En Revista: Hum Mutat Assunto da revista: GENETICA MEDICA Ano de publicação: 2015 Tipo de documento: Article